CDKN1A and cancer: In this review, we will focus on CDKN1A/p21, a protein central to key processes during metastatic spread, including cancer stem cell survival, epithelial–mesenchymal transition (EMT), and apoptosis, and discuss the described seemingly opposing roles [8] and potential uses as a predictive biomarker in metastatic breast cancer.